Julio Astudillo

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

Jean‐Yves Douillard, Rafael Rosell, Mario De Lena et al. · The Lancet Oncology · 2006 · 1.6K citations

Medicine, Oncology, Pharmacology +12

A Novel Anti-Apoptosis Gene: Re-expression of Survivin Messenger RNA as a Prognosis Marker in Non–Small-Cell Lung Cancers

Mariano Monzó, Rafael Rosell, Enriqueta Felip et al. · Journal of Clinical Oncology · 1999 · 496 citations

Life Sciences, Molecular Biology, Oncology +12

Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer

Enriqueta Felip, Rafael Rosell, J Maestre et al. · Journal of Clinical Oncology · 2010 · 430 citations · Full text

Medicine, Oncology, Surgery +17

Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients

José Luis Ramírez, Carme Sarries, Pedro López de Castro et al. · Cancer Letters · 2003 · 117 citations

Medicine, Genetics, Oncology +16

Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non–Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901

Pilar Garrido, J.L. González-Larriba, Amelia Insa et al. · Journal of Clinical Oncology · 2007 · 113 citations · Full text

Medicine, Oncology, Surgery +11